Literature DB >> 23378140

Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.

Rayna K Matsuno1, Mark E Sherman, Kala Visvanathan, Marc T Goodman, Brenda Y Hernandez, Charles F Lynch, Olga B Ioffe, David Horio, Charles Platz, Sean F Altekruse, Ruth M Pfeiffer, William F Anderson.   

Abstract

BACKGROUND: Emerging data suggest that ovarian cancers differ by tumor grade. However, the reliability of microscopic grade from paraffin tissue in the general medical community and as reflected in population-based cancer registries is unknown.
METHODS: We examined grade agreement between two gynecologic pathologists and the Surveillance Epidemiology and End Results Residual Tissue Repository (SEER). Grade agreement was assessed with percent observer agreement and kappa coefficients for 664 invasive ovarian carcinomas, using previously defined three-tier and two-tier grading systems. A random subset of ovarian carcinomas was selected to compare intra- and inter-pathologist agreement.
RESULTS: Five hundred and eighty-six of SEER's 664 tumors were confirmed invasive. Percent agreement was 49 % with fair kappa coefficient = 0.25 (95 % CI: 0.20-0.30) for the 664 tumors. Agreement improved slightly when restricted to the 586 confirmed invasive cancers; it was better for high grade than low grade tumors, for two-tier than three-tier grading systems, and within (66 %) than between study pathologists (43 %). Grade was not a robust independent predictor of ovarian cancer-specific survival.
CONCLUSIONS: Grade agreement was fair between SEER and study pathologists irrespective of grading system. Recorded grade in SEER should be used with caution and is probably not a reliable metric for ovarian cancer epidemiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378140      PMCID: PMC4000689          DOI: 10.1007/s10552-013-0157-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  28 in total

Review 1.  Histopathologic grading of ovarian carcinoma: a review and proposal.

Authors:  S G Silverberg
Journal:  Int J Gynecol Pathol       Date:  2000-01       Impact factor: 2.762

2.  High agreement but low kappa: II. Resolving the paradoxes.

Authors:  D V Cicchetti; A R Feinstein
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  High agreement but low kappa: I. The problems of two paradoxes.

Authors:  A R Feinstein; D V Cicchetti
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

4.  Classification and staging of malignant tumours in the female pelvis.

Authors: 
Journal:  Acta Obstet Gynecol Scand       Date:  1971       Impact factor: 3.636

5.  Diverse tumorigenic pathways in ovarian serous carcinoma.

Authors:  Gad Singer; Robert J Kurman; Hsueh-Wei Chang; Sarah K R Cho; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Grading ovarian serous carcinoma using a two-tier system.

Authors:  Anais Malpica; Michael T Deavers; Karen Lu; Diane C Bodurka; Edward N Atkinson; David M Gershenson; Elvio G Silva
Journal:  Am J Surg Pathol       Date:  2004-04       Impact factor: 6.394

Review 7.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

8.  Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

Authors:  Gad Singer; Ie-Ming Shih; Alexander Truskinovsky; Haldun Umudum; Robert J Kurman
Journal:  Int J Gynecol Pathol       Date:  2003-01       Impact factor: 2.762

9.  Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.

Authors:  Mario M Leitao; Jeff Boyd; Amanda Hummer; Narciso Olvera; Crispinita D Arroyo; Ennapadam Venkatraman; Rebecca N Baergen; Don S Dizon; Richard R Barakat; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2004-02       Impact factor: 6.394

Review 10.  Therapeutic strategies in epithelial ovarian cancer.

Authors:  Ayako Kim; Yutaka Ueda; Tetsuji Naka; Takayuki Enomoto
Journal:  J Exp Clin Cancer Res       Date:  2012-02-13
View more
  12 in total

Review 1.  The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.

Authors:  Máire A Duggan; William F Anderson; Sean Altekruse; Lynne Penberthy; Mark E Sherman
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

2.  Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity.

Authors:  Clara Bodelon; J Keith Killian; Joshua N Sampson; William F Anderson; Rayna Matsuno; Louise A Brinton; Jolanta Lissowska; Michael S Anglesio; David D L Bowtell; Jennifer A Doherty; Susan J Ramus; Aline Talhouk; Mark E Sherman; Nicolas Wentzensen
Journal:  Clin Cancer Res       Date:  2019-05-29       Impact factor: 12.531

Review 3.  SEER cancer registry biospecimen research: yesterday and tomorrow.

Authors:  Sean F Altekruse; Gabriel E Rosenfeld; Danielle M Carrick; Emilee J Pressman; Sheri D Schully; Leah E Mechanic; Kathleen A Cronin; Brenda Y Hernandez; Charles F Lynch; Wendy Cozen; Muin J Khoury; Lynne T Penberthy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

4.  Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.

Authors:  Mollie E Barnard; Alexander Pyden; Megan S Rice; Miguel Linares; Shelley S Tworoger; Brooke E Howitt; Emily E Meserve; Jonathan L Hecht
Journal:  Gynecol Oncol       Date:  2018-07-09       Impact factor: 5.482

5.  Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.

Authors:  Ana Babic; Daniel W Cramer; Linda E Kelemen; Martin Köbel; Helen Steed; Penelope M Webb; Sharon E Johnatty; Anna deFazio; Diether Lambrechts; Marc T Goodman; Florian Heitz; Keitaro Matsuo; Satoyo Hosono; Beth Y Karlan; Allan Jensen; Susanne K Kjær; Ellen L Goode; Tanja Pejovic; Melissa Moffitt; Estrid Høgdall; Claus Høgdall; Iain McNeish; Kathryn L Terry
Journal:  Cancer Causes Control       Date:  2017-01-03       Impact factor: 2.506

6.  Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.

Authors:  Nicolas Wentzensen; Elizabeth M Poole; Britton Trabert; Emily White; Alan A Arslan; Alpa V Patel; V Wendy Setiawan; Kala Visvanathan; Elisabete Weiderpass; Hans-Olov Adami; Amanda Black; Leslie Bernstein; Louise A Brinton; Julie Buring; Lesley M Butler; Saioa Chamosa; Tess V Clendenen; Laure Dossus; Renee Fortner; Susan M Gapstur; Mia M Gaudet; Inger T Gram; Patricia Hartge; Judith Hoffman-Bolton; Annika Idahl; Michael Jones; Rudolf Kaaks; Victoria Kirsh; Woon-Puay Koh; James V Lacey; I-Min Lee; Eva Lundin; Melissa A Merritt; N Charlotte Onland-Moret; Ulrike Peters; Jenny N Poynter; Sabina Rinaldi; Kim Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Leo J Schouten; Louise K Sjöholm; Sabina Sieri; Anthony Swerdlow; Anna Tjonneland; Ruth Travis; Antonia Trichopoulou; Piet A van den Brandt; Lynne Wilkens; Alicja Wolk; Hannah P Yang; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

7.  Examining the common aetiology of serous ovarian cancers and basal-like breast cancers using double primaries.

Authors:  Colin B Begg; Megan S Rice; Emily C Zabor; Shelley S Tworoger
Journal:  Br J Cancer       Date:  2017-03-23       Impact factor: 7.640

8.  Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers-Stage Challenges Categorical Assignments of Indolence & Aggressiveness.

Authors:  Edward J Pavlik; Christopher Smith; Taylor S Dennis; Elizabeth Harvey; Bin Huang; Quan Chen; Dava West Piecoro; Brian T Burgess; Anthony McDowell; Justin Gorski; Lauren A Baldwin; Rachel W Miller; Christopher P DeSimone; Charles Dietrich; Holly H Gallion; Frederick R Ueland; John R van Nagell
Journal:  Diagnostics (Basel)       Date:  2020-01-21

9.  Deciphering serous ovarian carcinoma histopathology and platinum response by convolutional neural networks.

Authors:  Kun-Hsing Yu; Vincent Hu; Feiran Wang; Ursula A Matulonis; George L Mutter; Jeffrey A Golden; Isaac S Kohane
Journal:  BMC Med       Date:  2020-08-18       Impact factor: 8.775

10.  Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

Authors:  Madalene A Earp; Linda E Kelemen; Anthony M Magliocco; Kenneth D Swenerton; Georgia Chenevix-Trench; Yi Lu; Alexander Hein; Arif B Ekici; Matthias W Beckmann; Peter A Fasching; Diether Lambrechts; Evelyn Despierre; Ignace Vergote; Sandrina Lambrechts; Jennifer A Doherty; Mary Anne Rossing; Jenny Chang-Claude; Anja Rudolph; Grace Friel; Kirsten B Moysich; Kunle Odunsi; Lara Sucheston-Campbell; Galina Lurie; Marc T Goodman; Michael E Carney; Pamela J Thompson; Ingo B Runnebaum; Matthias Dürst; Peter Hillemanns; Thilo Dörk; Natalia Antonenkova; Natalia Bogdanova; Arto Leminen; Heli Nevanlinna; Liisa M Pelttari; Ralf Butzow; Clareann H Bunker; Francesmary Modugno; Robert P Edwards; Roberta B Ness; Andreas du Bois; Florian Heitz; Ira Schwaab; Philipp Harter; Beth Y Karlan; Christine Walsh; Jenny Lester; Allan Jensen; Susanne K Kjær; Claus K Høgdall; Estrid Høgdall; Lene Lundvall; Thomas A Sellers; Brooke L Fridley; Ellen L Goode; Julie M Cunningham; Robert A Vierkant; Graham G Giles; Laura Baglietto; Gianluca Severi; Melissa C Southey; Dong Liang; Xifeng Wu; Karen Lu; Michelle A T Hildebrandt; Douglas A Levine; Maria Bisogna; Joellen M Schildkraut; Edwin S Iversen; Rachel Palmieri Weber; Andrew Berchuck; Daniel W Cramer; Kathryn L Terry; Elizabeth M Poole; Shelley S Tworoger; Elisa V Bandera; Urmila Chandran; Irene Orlow; Sara H Olson; Elisabeth Wik; Helga B Salvesen; Line Bjorge; Mari K Halle; Anne M van Altena; Katja K H Aben; Lambertus A Kiemeney; Leon F A G Massuger; Tanja Pejovic; Yukie T Bean; Cezary Cybulski; Jacek Gronwald; Jan Lubinski; Nicolas Wentzensen; Louise A Brinton; Jolanta Lissowska; Montserrat Garcia-Closas; Ed Dicks; Joe Dennis; Douglas F Easton; Honglin Song; Jonathan P Tyrer; Paul D P Pharoah; Diana Eccles; Ian G Campbell; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Joseph H Rothstein; James M Flanagan; James Paul; Robert Brown; Catherine M Phelan; Harvey A Risch; John R McLaughlin; Steven A Narod; Argyrios Ziogas; Hoda Anton-Culver; Aleksandra Gentry-Maharaj; Usha Menon; Simon A Gayther; Susan J Ramus; Anna H Wu; Celeste L Pearce; Malcolm C Pike; Agnieszka Dansonka-Mieszkowska; Iwona K Rzepecka; Lukasz M Szafron; Jolanta Kupryjanczyk; Linda S Cook; Nhu D Le; Angela Brooks-Wilson
Journal:  Hum Genet       Date:  2013-11-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.